Company Overview

Jaden BioScience Inc. (Jaden) specializes in developing and commercializing novel ultrasensitive in vitro research diagnostic assays for the scientific and medical communities. Our goal it to provide novel, high quality, easy-to-use assays that enhance scientific understanding, facilitate drug development, patient treatment and management.

Jaden's core technology is ultrasensitive chemiluminescent signal generation and detection systems capable of detecting 5 enzyme molecules in 5 microliters. These technology platforms can be applied to detect either protein or nucleic acid analytes. Our assays target PCR level sensitivity without signal-amplification or the use of costly equipment and highly trained laboratory technicians. Jaden's detection technology is adapted into simple to use assay formats using either 96 well microtiter plates or test tubes. Jaden's assays are performed in less than one hour. Jaden's first commercial research products are focused on the detection of cells and rare proteins. We believe that ultrasensitive detection of rare cells and proteins will have a significant impact in enabling new scientific discoveries and detecting and monitoring clinically relevant biomarkers.

Our technology is designed to facilitate the identification of biomarkers and diagnostic markers that can be used to enable scientific discoveries, and in the development of pharmaceutical drugs and ultimately, individual patient management.